课题基金 / 基金详情

Validation of rapid, molecular testing for COVID-19 and integration with TB diagnostics

Validation of rapid, molecular testing for COVID-19 and integration with TB diagnostics
验证 COVID-19 快速分子检测并与结核病诊断相结合
批准号：
429280
负责人：
Pai Madhukar
金额：
$0.0万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-05-01 至 2021-05-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=429280&lang=en
关键词：
Covid-19 Diagnostics Genexpert Tuberculosis

项目摘要

项目成果

Pai Madhukar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We are living in a world severely disrupted by the COVID-19 pandemic, but it is critical we do not neglect other diseases that persist outside of the global spotlight. Losing progress against the worldwide tuberculosis (TB) epidemic would mean adding to t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Empowering informal healthcare providers to detect tuberculosis using tongue swabs: a field-based, open-label, cluster randomized trial in India
Artificial intelligence-based analysis of cough for COVID-19 screening in Montreal
Canada Reseach Chair - Tier 1
  • 批准号：
    454237
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2021
  • 负责人：
    Pai Madhukar
  • 依托单位：
    McGill University
Summer Institute 2019: Engaging Global Leaders and Champions for Ending TB
海外基金